These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7501691)

  • 1. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
    Dragović D; Soskić V; Joksimović J
    Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
    Soskic V; Dukić S; Dragović D; Joksimović J
    Arzneimittelforschung; 1996 Aug; 46(8):741-6. PubMed ID: 9125270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and properties of several heterocyclic dopaminergic ligands.
    Kostić S; Soskić V; Joksimović J
    Arzneimittelforschung; 1994 Jun; 44(6):697-702. PubMed ID: 7914413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S; Soskić V; Joksimović J
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and binding properties of several new dopaminergic ligands.
    Tuce Z; Soskić V; Joksimović J
    Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrostatic surface potential calculation on several new halogenated benzimidazole-like dopaminergic ligands.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Jul; 337(7):376-82. PubMed ID: 15237387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs.
    Sukalović V; Andrić D; Roglić G; Kostić-Rajacić S; Schrattenholz A; Soskić V
    Eur J Med Chem; 2005 May; 40(5):481-93. PubMed ID: 15893022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
    Kostic-Rajacic A; Soskic V; Joksimovic J
    Boll Chim Farm; 1998 Nov; 137(10):417-21. PubMed ID: 10025971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
    Dukić S; Vujović M; Soskić V; Joksimović J
    Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U; Tränkle C; Mohr K; Gmeiner P
    Pharmazie; 1999 Apr; 54(4):294-7. PubMed ID: 10234741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed dopaminergic/serotonergic properties of several 2-substituted 4-[2-(5-benzimidazole)ethyl]-1-arylpiperazines.
    Kostic-Rajacic S; Soskic V; Joksimovic J
    Arch Pharm (Weinheim); 1998 Jan; 331(1):22-6. PubMed ID: 9507698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
    Dukić S; Kostić-Rajacić S; Dragović D; Soskić V; Joksimović J
    J Pharm Pharmacol; 1997 Oct; 49(10):1036-41. PubMed ID: 9364416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of N-n-propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine derivatives as dopamine receptor ligands.
    Claudi F; Giorgioni G; Di Stefano A; Renò F; Balduini W
    Drug Des Discov; 1992; 9(2):155-66. PubMed ID: 1296798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a methyl group in alpha- or beta-position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties.
    Roglic G; Andric D; Kostic-Rajacic S; Dukic S; Soskic V
    Arch Pharm (Weinheim); 2001 Dec; 334(12):375-80. PubMed ID: 11852532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
    Lan H; Durand CJ; Teeter MM; Neve KA
    Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
    Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
    Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of N-(2-phenylethyl)-N-n-propyl-2-(3-hydroxyphenyl) ethylamine derivatives as dopamine receptor ligands.
    Claudi F; Cardellini M; Di Stefano A; Giorgioni G; Cantalamessa F; Renò F; Balduini W
    Drug Des Discov; 1994 Feb; 11(2):115-25. PubMed ID: 7915549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.